TABLE 39A LIST OF PUBLICATIONS REFERRED TO IN THE ...

21.358 Calabrese LH et al. Viral Arthritis. Infect Dis Clin North Am 2005;19:963-80.
21.359 Morris CN et al. Parvovirus B19 infection associated with respiratory distress. Clin Infect Dis 1998;
27:900-1.
21.360 Barton LL. Cardiorespiratory manifestations of parvovirus B19 infection. Clin Infect Dis 1999;28:
1343.
21.361 McGhee SA et al. Persistent parvovirus-associated chronic fatigue treated with high dose intravenous
immunoglobulin. Pediatr Infect Dis J 2005;24:272-4.
21.362 Kumar J et al. Long-term remission of recurrent parvovirus B associated anemia in a renal transplant
recipient induced by treatment with immunoglobulin and positive seroconversion. Transpl Infect Dis
2005;7:30-3.
21.363 Kurtzman G et al. Pure red cell aplasia of 10 years‘ duration due to persistent parvovirus B19 infection
and its cure with immunoglobulin therapy. N Engl J Med 1989;321:519-23.
21.364 Koduri PR et al. Chronic pure red cell aplasia caused by parvovirus B19 in AIDS: use of intravenous
immunoglobulin. A report of eight patients. Am J Hematol 1999;61:16-20.
21.365 Eid AJ et al. Parvovirus B19 infection after transplantation: a review of 98 cases. Clin Infect Dis
2006;43:40-8.
21.366 Howard RS. Poliomyelitis and the postpolio syndrome. Br Med J 2005;330:1314-9.
21.367 Minor PD. Polio eradication, cessation of vaccination and re-emergence of disease. Nat Rev Microbiol
2004;2:473-82.
21.368 Hou J et al. Management of infections by the human polyomavirus JC: past, present and future. Expert
Rev Anti Infect Ther 2005;3:629-40.
21.369 Cinque P et al. Progressive multifocal leukoencephalopathy in HIV-1 infection. Lancet Infect Dis
2009;9:625-36.
21.370 Shitrit D et al. Progressive multifocal leuko-encephalopathy in transplant recipients. Transpl Int 2005;
17:658-65.
21.371 Crowder CD et al. Successful outcome of progressive multifocal leuko-encephalopathy in a renal
transplant recipient. Am J Transplant 2005;5:1151-8.
21.372 Chen Y et al. Asymptomatic reactivation of JC virus in patients treated with natalizumab. N Engl J
Med 2009;361:1067-74.
21.373 Langer-Gould A et al. Progressive multifocal leuko-encephalopathy in a patient treated with natalizumab.
N Engl J Med 2005;353:375-81.
21.374 Van Assche G et al. Progressive multifocal leuko-encephalopathy after natalizumab therapy for
Crohn‘s disease. N Engl J Med 2005;353:362-8.
21.375 Kleinschmidt-DeMasters BK et al. Progressive multifocal leuko-encephalopathy complicating treatment
with natalizumab and interferon beta-1a for multiple sclerosis. N Engl J Med 2005;353:369-74.
21.376 Miralles P et al. Treatment of AIDS associated progressive multifocal leuko-encephalopathy with
highly active antiretroviral therapy. AIDS 1998;12:2467-72.
21.377 Tantisiriwat W et al. Progressive multifocal leuko-encephalopathy in patients with AIDS receiving
highly active antiretroviral therapy. Clin Infect Dis 1999;28:1152-4.
21.378 Hall CD et al. Failure of cytarabine in progressive multifocal leuko-encephalopathy associated with
human immunodeficiency virus infection. N Engl J Med 1998;338:1345-51.
21.379 Cesaro S et al. Cidofovir for BK virus-associated hemorrhagic cystitis: a retrospective study. Clin Infect
Dis 2009;49:233-40.
21.380 Weinberg GA et al. BK virus nephropathy and other polyomavirus infections. Pediatr Infect Dis J
2010;29:257-60.
21.381 Hanssen Rinaldo C et al. Antivirals for the treatment of polyomavirus BK replication. Expert Rev Anti
Infect Ther 2007;5:105-15.
21.382 Muñoz P et al. Prevalence of BK virus replication among recipients of solid organ transplants. Clin Infect
Dis 2005;41:1720-5.
21.383 Reploeg MD et al. BK virus: a clinical review. Clin Infect Dis 2001;33:191-202.
21.384 Hirsch HH et al. Polyomavirus BK. Lancet Infect Dis 2003;3:611-23.
21.385 Vorou RM et al. Cowpox virus infection: an emerging health threat. Curr Opin Infect Dis 2008;21:
153-6.
21.386 Moore ZS et al. Smallpox. Lancet 2006;367:425-35.
21.387 Hosamani M et al. Orf: an update on current research and future perspectives. Expert Rev Anti Infect
Ther 2009;7:879-93.
21.388 Baker RO et al. Potential antiviral therapeutics for smallpox, monkeypox and other orthopoxvirus infections.
Antiviral Res 2003;57:13-23.
21.389 Rupprecht CE et al. Current and future trends in the prevention, treatment, and control of rabies.
Expert Rev Anti Infect Ther 2006;4:1021-38.
21.390 Hankins DG et al. Overview, prevention and treatment of rabies. Mayo Clin Proc 2004;79:671-6.
21.391 Warrell MJ et al. Rabies and other lyssavirus diseases. Lancet 2004;363:959-69.
21.392 Plotkin SA. Rabies. Clin Infect Dis 2000;30:4-12.
21.393 Jackson AC et al. Management of rabies in humans. Clin Infect Dis 2003;36:60-3.
21.394 Willoughby RE et al. Survival after treatment of rabies with induction of coma. N Engl J Med 2005;
352:2508-14.
21.395 Srinivasan A et al. Transmission of rabies virus from an organ donor to four transplant recipients. N
Engl J Med 2005;352:1103-11.
21.396 Nichols WG et al. Respiratory viruses other than influenza virus: impact and therapeutic advances.
Clin Microbiol Rev 2008;21:274-90.
21.397 Tregoning JS et al. Respiratory viral infections in infants: causes, clinical symptoms, virology, and immunology.
Clin Microbiol Rev 2010;23:74-98.
21.398 Lüsebrink J et al. Novel therapies for an old virus: treatment of RSV infections in the 21 st century. Expert
Rev Anti Infect Ther 2009;7:1125-9.
21.399 Sikkel MB et al. Respiratory syncytial virus persistence in chronic obstructive pulmonary disease. Pediatr
Infect Dis J 2008;27(suppl.):S63-70.
21.400 Boekh M et al. Randomized controlled multicenter trial of aerosolized ribavirin for respiratory syncytial
virus upper respiratory tract infection in hematopoietic cell transplant recipients. Clin Infect Dis 2007;
44:245-9.
21.401 Khanna N et al. Respiratory syncytial virus infection in patients with hematological diseases: singlecentre
study and review of the literature. Clin Infect Dis 2008;46:402-12.
21.402 Simoes EA. Respiratory syncytial virus infection. Lancet 1999;354:847-52.
21.403 Empey KM et al. Pharmacologic advances in the treatment and prevention of respiratory syncytial